4//SEC Filing
ALBIREO PHARMA, INC. 4
Accession 0001209191-16-148721
CIK 0001322505operating
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 6:41 PM ET
Size
7.8 KB
Accession
0001209191-16-148721
Insider Transaction Report
Form 4
Zorn Peter A
Senior VP, Corp Dev, GC & Sec
Transactions
- Award
Common Stock
2016-11-03+934→ 934 total - Award
Stock Option (right to buy)
2016-11-03+52,441→ 52,441 totalExercise: $1.00Exp: 2026-04-14→ Common Stock (52,441 underlying)
Footnotes (3)
- [F1]Represents shares of common stock of Albireo Pharma, Inc. (the "Issuer"), formerly known as Biodel Inc., issued in the share exchange transaction that was completed on November 3, 2016 pursuant to an Amended and Restated Share Exchange Agreement, dated as of July 13, 2016, by and among Biodel Inc., Albireo Limited ("Albireo") and the holders of Albireo shares and notes convertible into Albireo shares.
- [F2]This option was issued in replacement of an option to purchase shares of Albireo Limited.
- [F3]This option is vested and exercisable as to 33.33% of the underlying shares on the grant date, with the remainder vesting and becoming exercisable in 32 equal installments on the first day of each calendar month beginning with December 1, 2016 and ending July 1, 2019.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001322505
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 6:41 PM ET
- Size
- 7.8 KB